Please Wait

Applying Filters...

BETA-VAL
CEP/COS
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

BETA-VAL

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 18 USDMF, 11 CEP/COS, 4 JDMF, 9 EU WC, 2 KDMF, 8 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

123 FDF Dossiers, 34 FDA Orange Book, 43 Europe, 13 Canada, 18 Australia, 3 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - EQ 0.1% BASE, OINTMENT;TOPICAL - EQ 0.1% BASE, LOTION;TOPICAL - EQ 0.1% BASE, AEROSOL, FOAM;TOPICAL - 0.12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 DKSH, 4 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 3 Actylis, 16 BASF, 1 CD Formulation, 1 Clariant, 1 Corel Pharma Chem, 2 Esteem Industries, 2 Finar, 2 Gangwal Chemicals, 2 Lubrizol Life Science Health, 2 Nomisma Healthcare, 2 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

26 Topical, 12 Thickeners and Stabilizers, 10 Solubilizers, 6 Emulsifying Agents, 5 Controlled & Modified Release, 4 Parenteral, 4 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Lubricants & Glidants, 1 Coating Systems & Additives, 1 Direct Compression, 1 Taste Masking, 1 Rheology Modifiers

DIGITAL CONTENT

5 News #PharmaBuzz

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 9 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 5 JP, 2 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN	R1-CEP 2008-307 - Rev 00	Betamethasone valerate, Micronised	2016-04-08	Valid	Chemical		811
29/11/2025	Axplora	Germany	FARMABIOS S.p.A Gropello Cairoli IT	R1-CEP 2002-078 - Rev 03	Betamethasone valerate, Micronised	2021-03-22	Valid	Chemical		811

Contact us
to update this info

BETA-VAL

BETA-VAL

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

18 USDMF

11 CEP/COS

4 JDMF

9 EU WC

2 KDMF

8 NDC API

35 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

123 FDF Dossiers

34 FDA Orange Book

43 Europe

13 Canada

18 Australia

3 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - EQ 0.1% BASE

OINTMENT;TOPICAL - EQ 0.1% BASE

LOTION;TOPICAL - EQ 0.1% BASE

AEROSOL, FOAM;TOPICAL - 0.12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 DKSH

4 Nanjing Well Pharmaceutical

3 Kirsch Pharma

3 Actylis

16 BASF

1 CD Formulation

1 Clariant

1 Corel Pharma Chem

2 Esteem Industries

2 Finar

2 Gangwal Chemicals

2 Lubrizol Life Science Health

2 Nomisma Healthcare

2 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

26 Topical

12 Thickeners and Stabilizers

10 Solubilizers

6 Emulsifying Agents

5 Controlled & Modified Release

4 Parenteral

4 Film Formers & Plasticizers

3 Surfactant & Foaming Agents

2 Granulation

2 Lubricants & Glidants

1 Coating Systems & Additives

1 Direct Compression

1 Taste Masking

1 Rheology Modifiers

DIGITAL CONTENT

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions

9 Regulatory FDF Prices

MARKET PLACE

9 APIs

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM

5 JP

2 Others

Filters

AEROSOL, FOAM;TOPICAL - 0.12% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons